An abbreviated version of the Brain Care Score predicts risk for dementia, stroke, and late-life depression based on lifestyle factors alone.

The FDA has granted Fast Track designation to ST-503 for the treatment of small fiber neuropathy, a chronic neuropathic pain disorder.

Artificial intelligence-enabled point-of-care EEG allows rapid bedside seizure detection, accelerating treatment and preventing unnecessary care escalation.

The FDA has approved Uplizna for generalized myasthenia gravis in adults who are anti-AChR and anti-MuSK antibody positive.

Glucagon-like peptide-1 receptor agonist therapy is associated with a reduced risk for epilepsy in adults with type 2 diabetes mellitus.

New recommendations focused on psychological intervention may help manage or reduce the impact of functional seizures.

Suzanna's Kitchen breaded chicken has been recalled after soy, a major allergen, was not identified on the packaging.

Among women with fibromyalgia, overactive bladder is prevalent and may often be associated with higher symptom severity and comorbidity.

Baseline neuropsychiatric profiles in older adults stratify future cognitive decline, neuropathology, and risk for MCI or dementia.

Tolebrutinib failed to meet the primary endpoint in the phase 3 PERSEUS study involving patients with primary progressive multiple sclerosis.

Prehabilitation can reduce disability after surgery in older adults with frailty when compared with usual care.

In pediatric-onset multiple sclerosis, switching to oral or infusion therapies was linked to fewer relapses than switching between injectable treatments.